A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 40
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DT
Long Form : diphtheria-tetanus
No. Year Title Co-occurring Abbreviation
2022 Acupuncture-Associated Mycobacterium massiliense and Scedosporium Infections Superimposed by Tetanus. AFB
2022 Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines. HCWs, MMR
2022 Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls. LLPCs, OR, PRDs
2021 [Post-vaccination adverse events in the elderly in the State of Sao Paulo, Brazil, 2015 to 2017]. IE
2019 Diphteria-tetanus-pertussis vaccine reduces specific IgE, inflammation and remodelling in an animal model of mite-induced respiratory allergy. BAL, Derp, PMNs
2018 Immunization in end stage renal disease: The perception of waiting list patients. MMR
2013 Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection. BCR, DTaP, ICER
2009 High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations? ---
2007 [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines]. DTP, LA, Td, TT
10  2006 Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras. i.p, Ig, rhPRL
11  2006 Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. aP, Th
12  2005 Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. DTaP
13  2005 Improving quality by encouraging providers to use pediatric combination vaccines. MCOs
14  2005 [The vaccination coverage among children aged 24 - 30 months in pediatric offices November 1999 - May 2001. The influence of socio-demographic characteristics]. MMR, VC, VS
15  2004 Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. CI, DTP, HRs
16  2001 Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR. aDTP
17  2001 Impact of a vaccination campaign on adult immunity to diphtheria. ---
18  2001 Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. DTaP
19  2000 Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. CMI, DTaP, FHA, PT
20  1999 An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines. AIM, DTP
21  1999 Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. EPI, Hib, OPV
22  1999 Mothers and vaccination: knowledge, attitudes, and behaviour in Italy. DTP, OPV
23  1998 Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children. CMI, DTaP, FHA, GML, PRN, PT
24  1997 Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. CMI, DTaP, DTaP-CB, DTaP-SB
25  1997 Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. DTP
26  1997 Intranasal booster vaccination against diphtheria and tetanus in man. i.n
27  1997 The impact of sociodemographic variables on immunization coverage of children. MM, TBE
28  1996 Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. ---
29  1996 Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines. BP, DTP, IP
30  1996 Expanded programme on immunization (EPI) immunization schedules in the WHO Western Pacific Region, 1995. DPT, EPI, MMR, OPV, TT
31  1996 Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995. DPT, EPI, MMR, OPV, TT
32  1996 Expanded programme on immunization (EPI). Immunization schedules in the WHO eastern Mediterranean region, 1995. DPT, EPI, IPV, MMR, OPV
33  1994 Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. DTP
34  1993 Pertussis immunisation in children with a family or personal history of convulsions: a review of children referred for specialist advice. ---
35  1993 [The vaccinal prevention of diphtheria and tetanus in children suffering from bronchial asthma and asthmatic bronchitis]. ---
36  1991 [The specific prophylaxis of diphtheria in adults with adsorbed DT-m anatoxin]. ---
37  1989 [Use of adsorbed diphtheria-tetanus (DT) toxoid containing different doses of antigens in booster immunizations of children]. ---
38  1984 Symptoms after primary immunisation with DTP and with DT vaccine. DTP
39  1983 Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. DTP
40  1965 [Tetanus immunization of persons previously immunized against diphtheria with a combined diphtheria-tetanus (DT) preparation]. ---